ISO certifications for Kimia Farma
Indonesian state-owned pharmaceutical company Kimia Farma has receivedISO 9001, ISO 9002 and ISO 14001 certificates for its production units in Central and East Java. The company's president director, Mr Darodjatun, said that the ISO 9001 was certified for the company's manufacturing unit in Semarang, Central Java, while ISO 9002 and ISO 14001 were granted for the production facility in Watudakon, East Java.
Kimia Farma, one of the largest pharmaceutical companies in this country, has another six factories in Indonesia. These are located in Jakarta, Bandung, West Java and Tanjung Morawa, North Sumatra, in addition to the three production units in Central and East Java. It also produces medical raw materials and chemicals.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze